Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients
Clinical trial NCT00243529 · COMPLETED
Trial details
- NCT number
- NCT00243529
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2009-02-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.